Natalie Silver

Dr. Natalie Silver


Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2022 in Neoplasia
Verified
Journal Article
Open access
CMChieko Michikawa
Chieko Michikawa
VGVancheswaran Gopalakrishnan
Vancheswaran Gopalakrishnan
AHAmani M. Harrandah
Amani M. Harrandah
TKTatiana V Karpinets
Tatiana V Karpinets
RGRekha Rani Garg
Rekha Rani Garg
NSNatalie Silver
Natalie Silver
Recently, increased number of studies have demonstrated a relationship between the oral microbiome and development of head and neck cancer, however, there are few studies to investigate the role of oral bacteria in the context of the tumor microenvironment in a single head and neck subsite. Here, paired tumor and adjacent normal tissues from thirty-seven oral tongue squamous cell carcinoma (SCC) patients were subjected to 16S rRNA gene sequencing and whole exome sequencing (WES), in addition to RNA sequencing for tumor samples. We observed that Fusobacterium was significantly enriched in oral tongue cancer and that Rothia and Streptococcus were enriched in adjacent normal tissues. A decrease in alpha diversity was found in tumor when compared to adjacent normal tissues. While increased Fusobacterium in tumor samples was not associated with changes in immune cell infiltration, it was associated with increased PD-L1 mRNA expression. Therefore, we examined the effects of Fusobacterium on PD-L1 expression in head and neck SCC cell lines. We demonstrated that infection with Fusobacterium species can increase both PD-L1 mRNA and surface PD-L1 protein expression on head and neck cancer cell lines. The correlation between Fusobacterium and PD-L1 expression in oral tongue SCC, in conjunction with the ability of the bacterium to induce PD-L1 expression in vitro suggests a potential role for Fusobacterium on modulation of the tumor immune microenvironment in head and neck cancer.

23 February 2018 in BMC Public Health
Verified
Journal Article
Open access
PDF file
RSRamzi Salloum
Ramzi Salloum
TGThomas J George
Thomas J George
NSNatalie Silver
Natalie Silver
MMMerry-Jennifer Markham
Merry-Jennifer Markham
Jaclyn HallJaclyn Hall
Jaclyn Hall
ESElizabeth A. Shenkman
Elizabeth A. Shenkman
Access to direct-to-consumer genetic testing services has increased in recent years. However, disparities in knowledge and awareness of these services are not well documented. We examined awareness of genetic testing services by rural/urban and racial/ethnic status. Analyses were conducted using pooled cross-sectional data from 4 waves (2011–2014) of the Health Information National Trends Survey (HINTS). Descriptive statistics compared sample characteristics and information sources by rural/urban residence. Logistic regression was used to examine the relationship between geography, racial/ethnic status, and awareness of genetic testing, controlling for sociodemographic characteristics. Of 13,749 respondents, 16.7% resided in rural areas, 13.8% were Hispanic, and 10.1% were non-Hispanic black. Rural residents were less likely than urban residents to report awareness of genetic testing (OR = 0.74, 95% CI = 0.63–0.87). Compared with non-Hispanic whites, racial/ethnic minorities were less likely to be aware of genetic testing: Hispanic (OR = 0.68, 95% CI = 0.56–0.82); and non-Hispanic black (OR = 0.74, 95% CI = 0.61–0.90). Rural-urban and racial-ethnic differences exist in awareness of direct-to-consumer genetic testing. These differences may translate into disparities in the uptake of genetic testing, health behavior change, and disease prevention through precision and personalized medicine.

2 January 2026 in Nature Cancer
Verified
Journal Article
Open access
PDF file
NSNatalie Silver
Natalie Silver
JDJin Dai
Jin Dai
TKTravis D. Kerr
Travis D. Kerr
JAJessica Altemus
Jessica Altemus
RGRekha Garg
Rekha Garg
DMDaniel McGrail
Daniel McGrail
Despite the promise of immune checkpoint blockade (ICB) in head and neck squamous cell carcinoma (HNSCC), mediators of response are poorly understood. To address this, here we analyzed oropharyngeal HNSCCs treated with neoadjuvant durvalumab (anti-PDL1) alone or in combination with tremelimumab (anti-CTLA4) from the CIAO clinical trial ( NCT03144778 ). We found that only the total abundance of intratumoral bacteria predicted ICB response, which was validated in multiple independent cohorts. High intratumoral bacteria abundance was associated with an immunosuppressive tumor microenvironment, characterized by an accumulation of neutrophils coupled with depletion of T cells and other adaptive immune cells. Experimental elevation or reduction in intratumoral bacteria abundance in orthotopic models of HNSCC in female mice recapitulated immunological associations observed in participant tumors. Increasing intratumoral bacteria abundance was sufficient to induce resistance to anti-PDL1 ICB, irrespective of bacterial species tested. Together, these findings demonstrate that high intratumoral bacteria abundance is a key suppressor of antitumor immunity and promotes immunotherapy resistance.

5 March 2020 in Head & Neck
Verified
Journal Article
Closed access
PDF file
PDPeter Dziegielewski
Peter Dziegielewski
SBStewart Bernard
Stewart Bernard
WMWilliam M. Mendenhall
William M. Mendenhall
KHKathryn E Hitchcock
Kathryn E Hitchcock
CGCharles Parker Gibbs
Charles Parker Gibbs
RSRaja Sawhney
Raja Sawhney

6 January 2019 in The Laryngoscope
Verified
Journal Article
Closed access
PDF file
NSNatalie Silver
Natalie Silver
JDJustin Dourado
Justin Dourado
KHKathryn Hitchcock
Kathryn Hitchcock
AFAmy Fullerton
Amy Fullerton
KFKristianna Fredenburg
Kristianna Fredenburg
RFRoger B Fillingim
Roger B Fillingim

2 January 2026 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
NRNadeem Riaz
Nadeem Riaz
TATyler J. Alban
Tyler J. Alban
RHRobert I. Haddad
Robert I. Haddad
MSMichelle Saul
Michelle Saul
VMVladimir Makarov
Vladimir Makarov
TCTimothy A. Chan
Timothy A. Chan